EP1812063A4 - Anticorps monoclonaux du propeptide du candida albicans, et ses procédés d'utilisation - Google Patents

Anticorps monoclonaux du propeptide du candida albicans, et ses procédés d'utilisation

Info

Publication number
EP1812063A4
EP1812063A4 EP05825759A EP05825759A EP1812063A4 EP 1812063 A4 EP1812063 A4 EP 1812063A4 EP 05825759 A EP05825759 A EP 05825759A EP 05825759 A EP05825759 A EP 05825759A EP 1812063 A4 EP1812063 A4 EP 1812063A4
Authority
EP
European Patent Office
Prior art keywords
propeptide
methods
monoclonal antibodies
candida albicans
albicans
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05825759A
Other languages
German (de)
English (en)
Other versions
EP1812063A2 (fr
Inventor
Margaret K Hostetter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yale University
Original Assignee
Yale University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yale University filed Critical Yale University
Publication of EP1812063A2 publication Critical patent/EP1812063A2/fr
Publication of EP1812063A4 publication Critical patent/EP1812063A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56961—Plant cells or fungi
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/14—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/37—Assays involving biological materials from specific organisms or of a specific nature from fungi
    • G01N2333/39—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts
    • G01N2333/40—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts from Candida
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Botany (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP05825759A 2004-10-29 2005-10-31 Anticorps monoclonaux du propeptide du candida albicans, et ses procédés d'utilisation Withdrawn EP1812063A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62284504P 2004-10-29 2004-10-29
PCT/US2005/039431 WO2006050343A2 (fr) 2004-10-29 2005-10-31 Anticorps monoclonaux du propeptide du candida albicans, et ses procedes d'utilisation

Publications (2)

Publication Number Publication Date
EP1812063A2 EP1812063A2 (fr) 2007-08-01
EP1812063A4 true EP1812063A4 (fr) 2009-02-11

Family

ID=36319755

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05825759A Withdrawn EP1812063A4 (fr) 2004-10-29 2005-10-31 Anticorps monoclonaux du propeptide du candida albicans, et ses procédés d'utilisation

Country Status (2)

Country Link
EP (1) EP1812063A4 (fr)
WO (1) WO2006050343A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011035205A2 (fr) 2009-09-18 2011-03-24 Calmune Corporation Anticorps dirigés contre candida, leurs collectes et procédés d'utilisation
CN110885372A (zh) * 2019-12-17 2020-03-17 丹娜（天津）生物科技有限公司 一种抗念珠菌甘露聚糖的兔源单克隆抗体及其应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002026257A1 (fr) * 2000-09-28 2002-04-04 Yale University Anticorps du propeptide du candida albicans et ses procedes d'utilisation
US20030082680A1 (en) * 1996-05-03 2003-05-01 Regents Of The University Of Minnesota Candida albicans gene, integrin-like protein, antibodies, and methods of use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7138502B2 (en) * 2000-09-28 2006-11-21 Yale University Antibodies to the propeptide of Candida albicans and methods of use

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030082680A1 (en) * 1996-05-03 2003-05-01 Regents Of The University Of Minnesota Candida albicans gene, integrin-like protein, antibodies, and methods of use
WO2002026257A1 (fr) * 2000-09-28 2002-04-04 Yale University Anticorps du propeptide du candida albicans et ses procedes d'utilisation

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
GALE C A ET AL: "Linkage of adhesion, filamentous growth and virulence in candida albicans to a single gene, INT1", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, US, WASHINGTON, DC, vol. 279, 27 February 1998 (1998-02-27), pages 1355 - 1358, XP002954887, ISSN: 0036-8075 *
GALE C ET AL: "Cloning and expression of a gene encoding an integrin-like protein in Candida albicans.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 9 JAN 1996, vol. 93, no. 1, 9 January 1996 (1996-01-09), pages 357 - 361, XP002508457, ISSN: 0027-8424 *
HOSTETTER M K: "REVIEW INTEGRIN-LIKE PROTEINS IN CANDIDA SPP. AND OTHER MICROORGANISMS", FUNGAL GENETICS AND BIOLOGY, SAN DIEGO, CA, US, vol. 28, 1 January 1999 (1999-01-01), pages 135 - 145, XP002906434, ISSN: 1087-1845 *

Also Published As

Publication number Publication date
WO2006050343A3 (fr) 2006-11-02
EP1812063A2 (fr) 2007-08-01
WO2006050343A2 (fr) 2006-05-11

Similar Documents

Publication Publication Date Title
IL186659A0 (en) Il-31 monoclonal antibodies and methods of use
IL178593A (en) Specific antibodies of fcγriib and methods for their use
HK1099935A1 (en) Anti-cd3 antibodies and methods of use thereof -cd3
ZA200805741B (en) Anti-MN antibodies and methods of using same
HK1185085A1 (zh) 抗岩藻糖基- 的人單克隆抗體及使用抗岩藻糖基- 抗體的方法
IL179102A (en) Human-specific fcγriib antibodies and methods for their use
HK1199047A1 (en) Il-31 monoclonal antibodies and methods of use il-31
IL190502A0 (en) Anti-addl monoclonal antibody and use thereof
EP1717250A4 (fr) Anticorps monoclonal et utilisation de celui-ci
EP1868647A4 (fr) Anticorps se liant à ov064 et leurs méthodes d'utilisation
IL176755A0 (en) M-csf-specific monoclonal antibody and uses thereof
IL188748A0 (en) Anti-cd26 antibodies and methods of use thereof
EP1910513A4 (fr) Méthodes permettant d'isoler des cellules et de générer des anticorps monoclonaux
EP1787998A4 (fr) Anticorps et utilisation s'y rapportant
IL205511A0 (en) Methods and compositions for the production of monoclonal antibodies
EP1812065A4 (fr) Anticorps d'affinité élevée contre la hmgb1 et procédés d'utilisation
EP1940466A4 (fr) Anticorps monoclonal anti-addl et leur utilisation
IL182943A0 (en) Ovr110 antibody compositions and methods of use
SI1587542T1 (sl) Uporaba anti-cd100 protiteles
EP2048162A4 (fr) Nouvel anticorps monoclonal et son utilisation
EP1812063A4 (fr) Anticorps monoclonaux du propeptide du candida albicans, et ses procédés d'utilisation
HK1117849A1 (en) Anti-tnf-alpha antibodies and methods of use tnf
EP1333860A4 (fr) Anticorps du propeptide du candida albicans et ses procedes d'utilisation
EP1809670A4 (fr) Anticorps irta-4 et leurs utilisations
EP1944323A4 (fr) Nouvel anticorps monoclonal et utilisation de celui-ci

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070521

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20090113

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090825

R18D Application deemed to be withdrawn (corrected)

Effective date: 20090410